From Rous sarcoma virus to plasminogen activator, src oncogene and cancer management

Cellular processes of v-Src transformation revealed by gene profiling of primary cells - Implications for human cancer

(2010) Bart M Maślikowski et al.   BMC CANCER

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL

Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies

(2010) E. L. Mayer et al.   CLINICAL CANCER RESEARCH

Upstream Regulation of the Hippo Size Control Pathway

(2010) Felix A. Grusche et al.   CURRENT BIOLOGY

Modulators of the urokinase-type plasminogen activation system for cancer

(2010) Ralf Hildenbrand et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Y65C Missense Mutation in the WW Domain of the Golabi-Ito-Hall Syndrome Protein PQBP1 Affects Its Binding Activity and Deregulates Pre-mRNA Splicing

(2010) Victor E. Tapia et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of Tissue-Type Plasminogen Activator in Ischemic Stroke

(2010) Yasuhiro Suzuki   JOURNAL OF PHARMACOLOGICAL SCIENCES

Modularity in the Hippo signaling pathway

(2010) Marius Sudol et al.   TRENDS IN BIOCHEMICAL SCIENCES

SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer

(2009) Fred Saad et al.   CANCER TREATMENT REVIEWS

The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

(2009) Salvatore Ulisse et al.   CURRENT CANCER DRUG TARGETS

The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling

(2009) Francesco Blasi et al.   FEBS LETTERS

The urokinase receptor as an entertainer of signal transduction

(2009) Silvia D'Alessio   Frontiers in Bioscience-Landmark

Urokinase plasminogen activator system as a potential target for cancer therapy

(2009) Ahmed H Mekkawy et al.   Future Oncology

Feasibility of Measuring the Prognostic Factors uPA and PAI-1 in Core Needle Biopsy Breast Cancer Specimens

(2009) Christoph Thomssen et al.   JNCI-Journal of the National Cancer Institute

Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis

(2009) M. V. Carriero et al.   MOLECULAR CANCER THERAPEUTICS

Avian Sarcoma Virus and Human Immunodeficiency Virus, Type 1 Use Different Subsets of ESCRT Proteins to Facilitate the Budding Process

(2008) Andrew Pincetic et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Oncogenesis by retroviruses: old and new paradigms

(2008) Naoyoshi Maeda et al.   REVIEWS IN MEDICAL VIROLOGY